Indeed, results obtained in experimental models of MASLD suggest that targeting the endotoxin-TLR4 signaling cascade not only attenuated the development of MASLD but also the expression of TNFα [49]. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.